EW vs PRPL · P/E 47, rev $1.39B vs rev $487.9M
Edwards Lifesciences Corp (EW) versus Purple Innovation Inc (PRPL) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Purple Innovation Inc (PRPL) is a furnishings, fixtures & appliances company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported PRPL revenue for 2024-12-31 was $487.9M. Net income was -$98.1M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. PRPL currently screens at market cap $44.9M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PRPL currently screens at market cap $44.9M.
Not investment advice. Open the EW and PRPL stock pages for the full models.
Not investment advice.